Dr. Kaner is Associate Attending Physician at the New York Presbyterian Weill Cornell Center and Assciate Professor ofClinical Medicine and Genetic Medicine at Weill Cornell Medical College. He has expertise in interstitial lung diseases suchas idiopathic pulmonary fibrosis (IPF) and including those due to connective tissue diseases and directs a multidisciplinaryinterstitial lung disease conference. He has clinical expertise in lung complications of conditions such as HIV, cancer andcancer treatment including chemotherapy, radiation and bone marrow transplantation. He is the medical director of the VentilatorManagement Team.

Dr. Kaner is the Principal Investigator of the Weill-Cornell site of the National Instituteof Health (NIH)-sponsored Idiopathic Pulmonary Fibrosis Clinical Research Network, one of 11 in the US and the only centerin the Northeast/Mid-Atlantic region of the country. He is the project leader of an NIH-sponsored study of the molecular basisof accelerated emphysema development in HIV-1 positive smokers, which is part of a Specialized Center of Clinically OrientedResearch for chronic obstructive pulmonary disease (COPD) directed by Dr. R. Crystal. He has served as principal investigatorof NIH-sponsored basic research in mechanisms of vascular permeability in the lung and interactions of human alveolar macrophageswith HIV-1. He has participated in multicenter research studies in severe sepsis and nosocomial pneumonia.

Dr. Kaner is committed to research into the application of cutting edge molecular techniques to advance the understandingof pathophysiology, as well as to further improve the diagnosis and treatment of lung disease. He is board certified in internalmedicine, pulmonary disease and critical care medicine.

Clinical Expertise

Medical Practice(s)

Contact

• Phone 646-962-2333
• Fax 646-962-0110

• 1305 York Avenue
  4th Floor
• New York, NY 10021

Appointments

Board Certifications

Education